Comparison of Haloperidol and Dexmedetomidine for Delirium and Agitation in ICU Patients With Traumatic Brain Injury
Launched by BENHA UNIVERSITY · May 19, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is examining the effects of two different medications, haloperidol and dexmedetomidine, to help manage delirium and agitation in patients who have suffered a traumatic brain injury and are in the intensive care unit (ICU). Delirium is a state of confusion, while agitation refers to restlessness or extreme emotional disturbance. Both conditions are common in ICU patients and can make recovery more complicated and longer. The goal of the study is to see which medication is more effective and safer in treating these symptoms.
To participate in the trial, individuals must be adults aged 18 or older, have a confirmed traumatic brain injury, and be receiving mechanical ventilation in the ICU. They should also be showing signs of agitation, but not too severe. If someone is eligible and decides to participate, they will be randomly assigned to receive either haloperidol or dexmedetomidine. Throughout the study, their agitation and confusion levels will be closely monitored, and various tests will be conducted to ensure their safety. The findings from this research aim to help doctors make better treatment choices for ICU patients with traumatic brain injuries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged 18 years or older
- • Confirmed diagnosis of traumatic brain injury
- • Admission to the intensive care unit
- • Currently receiving mechanical ventilation
- • Richmond Agitation-Sedation Scale score between -5 and +4
- • At least 48 hours have passed since ICU admission
- Exclusion Criteria:
- • Pre-existing neurological or psychiatric disorders (e.g., schizophrenia, bipolar disorder)
- • Known allergy or contraindication to haloperidol or dexmedetomidine
- • Significant hepatic or renal dysfunction
- • Pregnant or breastfeeding women
- • History of prolonged QT interval or other cardiac arrhythmias
- • Use of long-term antipsychotic or sedative medications before ICU admission
About Benha University
Benha University, a leading institution in Egypt, is dedicated to advancing medical research and innovation through rigorous clinical trials. With a strong emphasis on multidisciplinary collaboration, the university aims to enhance healthcare outcomes by exploring novel therapeutic approaches and interventions. Its state-of-the-art facilities and commitment to ethical research practices ensure that all trials are conducted with the highest standards of integrity and scientific rigor. Benha University actively contributes to the global medical community by fostering partnerships and disseminating findings that can improve patient care and inform public health policies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported